for the 12 mg dose, 100%, 93%, and 83% [19]
That said, peptide therapy is not for everyone
primary-cta How to Access GHK-Cu Through Licensed Providers Eden enables access to licensed healthcare providers who evaluate personal wellness goals and determine whether compounded medications, such as GHK-Cu, may be appropriate
On 15 April 2026, the FDA gave notice to remove BPC-157 and other peptides from Category 2, because the nominations were withdrawn
Product overview BPC-157 25mg sits in the Peptides category and is listed in a 5mg / vial format
Alterations in the kynurenine pathway and excitatory amino acid transporter-2 in depression with and without psychosis: evidence of a potential astrocyte pathology